Verbraecken Johan, Dieltjens Marijke, Op de Beeck Sara, Vroegop Anneclaire, Braem Marc, Vanderveken Olivier, Randerath Winfried
Department of Pulmonary Medicine, Antwerp University Hospital, Edegem (Antwerp), Belgium.
Multidisciplinary Sleep Disorders Centre, Antwerp University Hospital, Edegem, Belgium.
Breathe (Sheff). 2022 Sep;18(3):220164. doi: 10.1183/20734735.0164-2022. Epub 2022 Oct 11.
Treatment of obstructive sleep apnoea in adults is evolving, from a "one treatment fits all" to a more individualised approach. The spectrum of treatment options is broad and heterogeneous, including conservative, technological and pharmaceutical modalities. This raises the questions of which patients these modalities might be useful for, and if there are specific criteria for single or combined treatment. The most commonly used non-CPAP treatment is a mandibular advancement device. Furthermore, it appears from the available evidence that upper airway surgery, bariatric surgery, and maxillomandibular advancement can be effective in particular patient groups and should be indicated more readily in clinical practice. Technically, a tracheotomy is the most effective surgical treatment, but is not socially acceptable and is associated with major side-effects. Other treatment options are emerging, like positional therapy, hypoglossal nerve stimulation, and myofunctional exercises. Drug therapy is also promising when pathophysiological traits are considered. The range of currently available treatment options will be discussed in this review, with emphasis on the selection of appropriate patients, therapeutic efficacy and compliance, and reference to recent guidelines. In the selection process, routine application of drug-induced sleep endoscopy to assess the site(s) of collapse during sleep can increase the success rate of both surgical interventions and oral appliance therapy.
To outline recommendations concerning the proper management of obstructive sleep apnoea (OSA) patients that cannot be treated adequately with continuous positive airway pressure (CPAP) due to intolerance, poor adherence or compliance, or CPAP refusal.To provide information about the selection of appropriate patients for alternative non-CPAP treatment options.To better understand the different aspects of OSA treatment with noninvasive approaches, such as oral appliances, positional therapy, drug treatment and myofunctional therapy, including indications, contraindications, and expected short- and long-term results.To discuss the different surgical options for the treatment of OSA and to provide information on the important issue of proper patient selection for surgery, as most OSA surgical outcomes are associated with the pre-operative assessment of the level(s) of upper airway collapse.
成人阻塞性睡眠呼吸暂停的治疗方法正在不断发展,从“一刀切”的治疗方式转变为更加个体化的治疗方法。治疗选择的范围广泛且多样,包括保守治疗、技术治疗和药物治疗等方式。这就引发了这些治疗方式对哪些患者可能有用,以及单一治疗或联合治疗是否存在特定标准的问题。最常用的非持续气道正压通气(CPAP)治疗方法是下颌前移装置。此外,现有证据表明,上气道手术、减重手术和上颌下颌前移手术在特定患者群体中可能有效,在临床实践中应更易于应用。从技术上讲,气管切开术是最有效的手术治疗方法,但不被社会所接受,且伴有严重的副作用。其他治疗选择也在不断涌现,如体位治疗、舌下神经刺激和肌功能锻炼。当考虑病理生理特征时,药物治疗也很有前景。本综述将讨论目前可用的治疗选择范围,重点是合适患者的选择、治疗效果和依从性,并参考最新指南。在选择过程中,常规应用药物诱导睡眠内镜检查以评估睡眠期间塌陷部位,可提高手术干预和口腔矫治器治疗的成功率。
概述关于因不耐受、依从性差或拒绝使用CPAP而无法通过持续气道正压通气(CPAP)充分治疗的阻塞性睡眠呼吸暂停(OSA)患者的适当管理建议。提供有关为替代非CPAP治疗选择选择合适患者的信息。更好地理解采用无创方法治疗OSA的不同方面,如口腔矫治器、体位治疗、药物治疗和肌功能治疗,包括适应症、禁忌症以及预期的短期和长期效果。讨论治疗OSA的不同手术选择,并提供有关手术患者正确选择这一重要问题的信息,因为大多数OSA手术结果与上气道塌陷水平的术前评估有关。